MindImmune Therapeutics Announces $12.4 million Series A Financing



Comments are closed.

Technology and business giants David Dolby and Mark Knickrehm join Salk’s Board
AccuKnox Raises $6M in Seed Funding for Zero Trust CNAPP and KubeArmor OpenSource Project
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Eargo Is The Hearing Aid Of The Future